Quantitative assessment of the association between HDMX polymorphism and sarcoma

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• The HDMX gene plays a role in tumor suppression.
• Genetic variations, such as polymorphisms, can influence cancer risk.
• Understanding the impact of specific gene polymorphisms on sarcoma development is crucial.

Purpose of the Study:

• To investigate the association between the HDMX gene polymorphism and the risk of developing sarcoma.
• To synthesize existing evidence through a comprehensive meta-analysis.

Main Methods:

• A systematic literature search was conducted across PubMed, Embase, and Web of Science databases.
• Data from four case-control studies, including 1,115 participants (379 cases, 736 controls), were meta-analyzed.
• Statistical analyses, including heterogeneity, sensitivity, and publication bias tests, were performed.

Main Results:

• The meta-analysis revealed no statistically significant association between the HDMX polymorphism and sarcoma risk across various genetic models and allele comparisons.
• Results remained consistent after stratification by ethnicity.
• No significant heterogeneity was observed among the included studies.

Conclusions:

• The HDMX gene polymorphism is unlikely to be a significant factor in individual susceptibility to sarcoma.
• Further research may be warranted to explore other genetic or environmental factors in sarcoma etiology.